Iotrolan
Generic Name: iotrolan
Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INTRATHECAL. Active ingredients: IOTROLAN (40.6%). Application: NDA019580.
Overview
Manufactured by BAYER HLTHCARE. Dosage form: INJECTABLE. Route: INTRATHECAL. Active ingredients: IOTROLAN (40.6%). Application: NDA019580.
Dosage
Available as injectable for intrathecal use.
Related Medications
Glycerin 6%,lidocaine 4%,ectoin 0.12%
glycerin 6%,lidocaine 4%,ectoin 0.12%
Non-Standardized Chemical Allergen [EPC]
OTC-PURPOSE SECTION OTC-PURPOSE SECTION OTC-PURPOSE SECTION
Anagrelide
anagrelide
11 DESCRIPTION Anagrelide hydrochloride, USP is a platelet-reducing agent. Its chemical name is 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one monohydrochloride monohydrate. The molecular formula is C 10 H 7 Cl 2 N 3 O•HCl•H 2 O which corresponds to a molecular weight of 310.59. The structural formula is: Anagrelide hydrochloride is an off-white powder. It is very slightly soluble in water and sparingly soluble in dimethyl sulfoxide and dimethylformamide.
Glyburide-metformin Hydrochloride
glyburide-metformin hydrochloride
Sulfonylurea [EPC]
11 DESCRIPTION Glyburide and metformin hydrochloride tablets, USP contain 2 oral antihyperglycemic drugs used in the management of type 2 diabetis, glyburide USP and metformin hydrochloride USP. Glyburide, USP is an oral antihyperglycemia sulfonylurea class. The chemical name for glyburide USP is 1-[[ p -[2-(5-chloro- o -anisamido) ethyl]phenyl]sulfonyl]-3-cyclo-hexylurea.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.